These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
247 related articles for article (PubMed ID: 14982906)
21. Feasibility of implementing magnesium sulphate for neuroprotection in a tertiary obstetric unit. Ow LL; Kennedy A; McCarthy EA; Walker SP Aust N Z J Obstet Gynaecol; 2012 Aug; 52(4):356-60. PubMed ID: 22515404 [TBL] [Abstract][Full Text] [Related]
22. Contemporary usage of obstetric magnesium sulfate: indication, contraindication, and relevance of dose. Gonen R Obstet Gynecol; 2010 Jan; 115(1):186. PubMed ID: 20027061 [No Abstract] [Full Text] [Related]
23. Association of duration of neuroprotective magnesium sulfate infusion with neonatal and maternal outcomes. McPherson JA; Rouse DJ; Grobman WA; Palatnik A; Stamilio DM Obstet Gynecol; 2014 Oct; 124(4):749-755. PubMed ID: 25198275 [TBL] [Abstract][Full Text] [Related]
24. Effect of magnesium sulfate administration for neuroprotection on latency in women with preterm premature rupture of membranes. Horton AL; Lai Y; Rouse DJ; Spong CY; Leveno KJ; Varner MW; Mercer BM; Iams JD; Wapner RJ; Sorokin Y; Thorp JM; Ramin SM; Malone FD; O'Sullivan MJ; Hankins GD; Caritis SN; Am J Perinatol; 2015 Mar; 32(4):387-92. PubMed ID: 25241107 [TBL] [Abstract][Full Text] [Related]
25. Association between use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Mittendorf R; Pryde PG; Lee KS Am J Obstet Gynecol; 2003 Aug; 189(2):613. PubMed ID: 14524362 [No Abstract] [Full Text] [Related]
27. Magnesium sulphate for fetal neuroprotection. Costa Fda S; Lopes L; Brennecke S Rev Bras Ginecol Obstet; 2011 Jun; 33(6):265-70. PubMed ID: 21877014 [No Abstract] [Full Text] [Related]
28. Magnesium sulfate for the prevention of cerebral palsy. Rouse DJ Am J Obstet Gynecol; 2009 Jun; 200(6):610-2. PubMed ID: 19482114 [TBL] [Abstract][Full Text] [Related]
29. Effects and Safety of Magnesium Sulfate on Neuroprotection: A Meta-analysis Based on PRISMA Guidelines. Zeng X; Xue Y; Tian Q; Sun R; An R Medicine (Baltimore); 2016 Jan; 95(1):e2451. PubMed ID: 26735551 [TBL] [Abstract][Full Text] [Related]
33. Magnesium sulfate for fetal neuroprotection. Rouse DJ Am J Obstet Gynecol; 2011 Oct; 205(4):296-7. PubMed ID: 22083052 [No Abstract] [Full Text] [Related]
34. Is the pharmacological use of intravenous magnesium before preterm cerebroprotective or deleterious for premature infants? Possible importance of the use of magnesium sulphate. Durlach J; Bac P; Bara M; Guiet-Bara A Magnes Res; 1998 Dec; 11(4):323-5. PubMed ID: 9884990 [No Abstract] [Full Text] [Related]
35. Adherence to uptake of magnesium sulphate for neuroprotection in preterm births <30 weeks at Christchurch Hospital. Pang J N Z Med J; 2017 Jul; 130(1458):52-53. PubMed ID: 28694540 [No Abstract] [Full Text] [Related]